Answer
Breastfeeding is not recommended with Emtricitabine/Rilpivirine/Tenofovir Disoproxil Gilead because emtricitabine and tenofovir disoproxil enter human milk, rilpivirine excretion is unknown, infant effects are insufficiently understood with potential adverse reactions, and breastfeeding can transmit HIV.
Sources for this answer
- Emtricitabine/Rilpivirine/Tenofovir Disoproxil Gilead 200 mg/25 mg/245 mg film coated tabletsGilead Sciences Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 33Document updated
Sources checked